Sign In to Follow Application
View All Documents & Correspondence

Pharmaceutical Composition Comprising Sphingosine 1 Phosphate Receptor Agonist With Controlled Particle Size

Abstract: The present invention relates to a pharmaceutical composition comprising a sphingosine-1-phosphate receptor agonist with a controlled particle size and, more specifically, to a pharmaceutical composition comprising: as an active ingredient, 1-[1-chloro-6-(3-chloro-1-isopropyl-1H-indazole-5-ylmethoxy)-3,4-dihydro-naphthalene-2-ylmethyl]-piperidine-4-carboxylic acid of chemical formula 1 or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, wherein the particle size d(0.9) of the active ingredient is 60 µm or less.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
11 November 2023
Publication Number
38/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

LG CHEM, LTD.
128, Yeoui-daero Yeongdeungpo-gu Seoul 07336

Inventors

1. YUN, Duck Il
E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796
2. HAN, Hae Ju
E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796
3. MIN, Hyun Hong
E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796
4. KIM, Ji Young
E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

Specification

Documents

Application Documents

# Name Date
1 202317077141-STATEMENT OF UNDERTAKING (FORM 3) [11-11-2023(online)].pdf 2023-11-11
2 202317077141-REQUEST FOR EXAMINATION (FORM-18) [11-11-2023(online)].pdf 2023-11-11
3 202317077141-PRIORITY DOCUMENTS [11-11-2023(online)].pdf 2023-11-11
4 202317077141-POWER OF AUTHORITY [11-11-2023(online)].pdf 2023-11-11
5 202317077141-FORM 18 [11-11-2023(online)].pdf 2023-11-11
6 202317077141-FORM 1 [11-11-2023(online)].pdf 2023-11-11
7 202317077141-DRAWINGS [11-11-2023(online)].pdf 2023-11-11
8 202317077141-DECLARATION OF INVENTORSHIP (FORM 5) [11-11-2023(online)].pdf 2023-11-11
9 202317077141-COMPLETE SPECIFICATION [11-11-2023(online)].pdf 2023-11-11
10 202317077141-Proof of Right [07-05-2024(online)].pdf 2024-05-07
11 202317077141-FORM 3 [07-05-2024(online)].pdf 2024-05-07